ALEXANDRIA, Va., Oct. 6 -- United States Patent no. 12,753,398, issued on Oct. 6, was assigned to LIMAGRAIN EUROPE (Saint-Beauzire, France).

"CRISPR-mediated directed codon re-write" was invented by Thierry Risacher (Clermont-Ferrand, France).

According to the abstract* released by the U.S. Patent & Trademark Office: "The invention relates to methods for introducing mutation within genes, which use the errors in the reparation machinery of the cell, and introduction of deletions and/or insertions when repairing a cleavage made by an endonuclease, in particular using the CRISPR system."

The patent was filed on Oct. 1, 2021, under Application No. 18/027,530.

*For further information, including images, charts and tables, please visit: http...